LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

View


Related Resources

Download

LacriJet®

November 13, 2018 – 10.53 MB PDF

LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration.

Download

Oculoplastics Product Catalog

August 5, 2019 – 3.52 MB PDF

FCI S.A.S. is a world leader in the development of a wide range of ophthalmic surgical devices. Since the company’s inception in 1984, the innovative developments of FCI have helped physicians to solve problems related to epiphora, dry eye, eyelids, and orbital surgery, thanks to a wide range of innovative ophthalmic devices such as self-retaining intubation sets, lacrimal balloon catheter, injectable monocanalicular intubation, permanent punctal plugs, eyelids and orbital implants.

Categories